An adaptationist perspective on the etiology of depression

Journal of Affective Disorders

Volumn 172, Issue , 2015, Pages 315-323

  Durisko, Zachary ^a,b   Mulsant, Benoit H ^a,c   Andrews, Paul W ^b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Darwinian Medicine; Evolution; Evolutionary Psychiatry; Major depressive disorder

Indexed keywords

ANTIDEPRESSANT AGENT;

ADAPTIVE BEHAVIOR; COGNITIVE THERAPY; DECISION MAKING; DEPRESSION; DRUG USE; ELECTROCONVULSIVE THERAPY; HUMAN; MAJOR DEPRESSION; NEUROTRANSMISSION; NONHUMAN; PSYCHOTHERAPY; REVIEW; SOCIAL ADAPTATION; ADULT; COGNITION; DAILY LIFE ACTIVITY; DEPRESSIVE DISORDER, MAJOR; FEMALE; MALE; PSYCHOLOGY; SYNAPTIC TRANSMISSION;

ACTIVITIES OF DAILY LIVING; ADAPTATION, PSYCHOLOGICAL; ADULT; ANTIDEPRESSIVE AGENTS; COGNITION; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; SYNAPTIC TRANSMISSION;

EID: 84908432721     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2014.09.032     Document Type: Review

References (158)

1. M. Addis, and N. Jacobson Reasons for depression and the process and outcome of cognitive-behavioral psychotherapies J. Consult. Clin. Psychol. 64 1996 1417 1424
2. K.K. Akiskal, and H.S. Akiskal The theoretical underpinnings of affective temperaments: implications for evolutionary foundations of bipolar disorder and human nature J. Affect. Disord. 85 2005 231 239
3. N.B. Allen, and P.B.T. Badcock The social risk hypothesis of depressed mood: evolutionary, psychosocial, and neurobiological perspectives Psychol. Bull. 129 2003 887 913
4. J.D. Amsterdam, D. Williams, D. Michelson, L.A. Adler, D.L. Dunner, A.A. Nierenberg, F.W. Reimherr, and A.F. Schatzberg Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder Neuropsychobiology 59 2009 227 233
5. H.D. Anderson, W.D. Pace, A.M. Libby, D.R. West, and R.J. Valuck Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study Clin. Ther. 34 2012 113 123
6. P.W. Andrews Parent-offspring conflict and cost-benefit analysis in adolescent suicidal behavior Hum. Nat. 17 2006 190 211
7. Andrews P.W., Durisko Z., 2014. The evolution of depressive phenotypes: sickness behavior, starvation, and melancholia (Submitted for publication).
8. P.W. Andrews, S.W. Gangestad, and D. Matthews Adaptationism - how to carry out an exaptationist program Behav. Brain Sci. 25 2002 489 504 (discussion 504-53)
9. P.W. Andrews, S.G. Kornstein, L.J. Halberstadt, C.O. Gardner, and M.C. Neale Blue again: perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression Front. Psychol. 2 2011 159
10. P.W. Andrews, and J.A. Thomson The bright side of being blue: depression as an adaptation for analyzing complex problems Psychol. Rev. 116 2009 620 654
11. P.W. Andrews, J.A. Thomson, A. Amstadter, and M.C. Neale Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good Front. Psychol. 3 2012 117
12. B. Arroll, C. Elley, T. Fishman, F. Goodyear-Smith, T. Kenealy, G. Blashki, N. Kerse, and S. MacGillivray Antidepressants versus placebo for depression in primary care Cochrane Database Syst. Rev. 3 2009 CD007954
13. K.A. Baikie, L. Geerligs, and K. Wilhelm Expressive writing and positive writing for participants with mood disorders: an online randomized controlled trial J. Affect. Disord. 136 2012 310 319
14. Barbic, S.P., Durisko, Z., Andrews, P.W., 2014. Measuring the bright side of being blue: a new tool for assessing analytical rumination in depression, PLoS ONE, In Press
15. J. Barth, T. Munder, H. Gerger, E. Nüesch, S. Trelle, H. Znoj, P. Jüni, and P. Cuijpers Comparative efficacy of seven psychotherapeutic interventions for patients with depression: a network meta-analysis PLoS Med. 10 2013 e1001454
16. W.T. Boyce, and B.J. Ellis Biological sensitivity to context: I. An evolutionary-developmental theory of the origins and functions of stress reactivity Dev. Psychopathol. 17 2005 271 301
17. G.H. Brody, S.R.H. Beach, R.A. Philibert, Y. Chen, and V.M. Murry Prevention effects moderate the association of 5-HTTLPR and youth risk behavior initiation: gene x environment hypotheses tested via a randomized prevention design Child Dev. 80 2009 645 661
18. G.H. Brody, S.R.H. Beach, R.A. Philibert, Y.-F. Chen, M.-K. Lei, V.M. Murry, and A.C. Brown Parenting moderates a genetic vulnerability factor in longitudinal increases in youths' substance use J. Consult. Clin. Psychol. 77 2009 1 11
19. G.H. Brody, Y.-F. Chen, S.R.H. Beach, R.A. Philibert, and S.M. Kogan Participation in a family-centered prevention program decreases genetic risk for adolescents' risky behaviors Pediatrics 124 2009 911 917
20. E. Bromet, L.H. Andrade, I. Hwang, N.A. Sampson, J. Alonso, G. de Girolamo, R. de Graaf, K. Demyttenaere, C. Hu, N. Iwata, A.N. Karam, J. Kaur, S. Kostyuchenko, J.-P. Lépine, D. Levinson, H. Matschinger, M.E.M. Mora, M.O. Browne, J. Posada-Villa, M.C. Viana, D.R. Williams, and R.C. Kessler Cross-national epidemiology of DSM-IV major depressive episode BMC Med. 9 2011 90
21. A.C. Butler, J.E. Chapman, E.M. Forman, and A.T. Beck The empirical status of cognitive-behavioral therapy: a review of meta-analyses Clin. Psychol. Rev. 26 2006 17 31
22. S.E. Byrne, and A.J. Rothschild Loss of antidepressant efficacy during maintenance therapy: possible mechanisms and treatments J. Clin. Psychiatry 59 1998 279 288
23. B.G. Case, D.N. Bertollo, E.M. Laska, L.H. Price, C.E. Siegel, M. Olfson, and S.C. Marcus Declining use of electroconvulsive therapy in United States general hospitals Biol. Psychiatry 73 2013 119 126
24. W.M. Compton, K.P. Conway, F.S. Stinson, and B.F. Grant Changes in the prevalence of major depression and comorbid substance use disorders in the United States between 1991-1992 and 2001-2002 Am. J. Psychiatry 163 2006 2141 2147
25. L. Cosgrove, L. Shi, D.E. Creasey, M. Anaya-McKivergan, J.A. Myers, and K.F. Huybrechts Antidepressants and breast and ovarian cancer risk: a review of the literature and researchers' financial associations with industry PLoS One 6 2011 e18210
26. J.F. Crow Development. There's something curious about paternal-age effects Science 301 2003 606 607
27. P. Cuijpers, A. van Straten, G. Andersson, and P. van Oppen Psychotherapy for depression in adults: a meta-analysis of comparative outcome studies J. Consult. Clin. Psychol. 76 2008 909 922
28. P. Cuijpers, A. van Straten, and L. Warmerdam Behavioral activation treatments of depression: a meta-analysis Clin. Psychol. Rev. 27 2007 318 326
29. R. Dantzer Cytokine-induced sickness behavior: where do we stand? Brain. Behav. Immun. 15 2001 7 24
30. R. Dantzer, J.C. O'Connor, G.G. Freund, R.W. Johnson, and K.W. Kelley From inflammation to sickness and depression: when the immune system subjugates the brain Nat. Rev. Neurosci. 9 2008 46 56
31. J.R.T. Davidson Major depressive disorder treatment guidelines in America and Europe J. Clin. Psychiatry 71 Suppl. E 2010 Se04
32. C. Davis, and R.D. Levitan Seasonality and seasonal affective disorder (SAD): an evolutionary viewpoint tied to energy conservation and reproductive cycles J. Affect. Disord. 87 2005 3 10
33. A. Di Rienzo, and R.R. Hudson An evolutionary framework for common diseases: the ancestral-susceptibility model Trends Genet. 21 2005 596 601
34. S. Dimidjian, S.D. Hollon, K.S. Dobson, K.B. Schmaling, R.J. Kohlenberg, M.E. Addis, R. Gallop, J.B. McGlinchey, D.K. Markley, J.K. Gollan, D.C. Atkins, D.L. Dunner, and N.S. Jacobson Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression J. Consult. Clin. Psychol. 74 2006 658 670
35. K.S. Dobson, S.D. Hollon, S. Dimidjian, K.B. Schmaling, R.J. Kohlenberg, R.J. Gallop, S.L. Rizvi, J.K. Gollan, D.L. Dunner, and N.S. Jacobson Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression J. Consult. Clin. Psychol. 76 2008 468 477
36. K.S. Dobson, S.D. Hollon, S. Dimidjian, K.B. Schmaling, R.J. Kohlenberg, R.J. Gallop, S.L. Rizvi, J.K. Gollan, D.L. Dunner, and N.S. Jacobson Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression J. Consult. Clin. Psychol. 76 2008 468 477
37. M.S. Durkin, M.J. Maenner, C.J. Newschaffer, L.-C. Lee, C.M. Cunniff, J.L. Daniels, R.S. Kirby, L. Leavitt, L. Miller, W. Zahorodny, and L.A. Schieve Advanced parental age and the risk of autism spectrum disorder Am. J. Epidemiol. 168 2008 1268 1276
38. J.M. Eagles Seasonal affective disorder: a vestigial evolutionary advantage? Med. Hypotheses 63 2004 767 772
39. M.S. Eghøj, and T.L. Sørensen Tachyphylaxis during treatment of exudative age-related macular degeneration with ranibizumab Br. J. Ophthalmol. 96 2012 21 23
40. B.J. Ellis, and W.T. Boyce Differential susceptibility to the environment: toward an understanding of sensitivity to developmental experiences and context Dev. Psychopathol. 23 2011 1 5
41. R. El-Mallakh, Y. Gao, and R.J. Roberts Tardive dysphoria: the role of long term antidepressant use in-inducing chronic depression Med. Hypotheses 76 2011 769 773
42. G. Engel, and A. Schmale Conservation withdrawal: a primary regulatory process for organic homeostasis Physiology, Emotions and Psychosomatic Illness 1972 Elsevier New York 57 95
43. G. Fava Can long-term treatment with antidepressant drugs worsen the course of depression? J. Clin. Psychiatry 64 2003 123 133
44. A.J. Ferrari, A.J. Somerville, A.J. Baxter, R. Norman, S.B. Patten, T. Vos, and H.A. Whiteford Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature Psychol. Med. 43 2013 471 481
45. A. Frances The new crisis in confidence in psychiatric diagnosis Ann. Intern. Med. 2013 5 7
46. E.M. Frans, S. Sandin, A. Reichenberg, P. Lichtenstein, N. Långström, and C.M. Hultman Advancing paternal age and bipolar disorder Arch. Gen. Psychiatry 65 2008 1034 1040
47. G. Gartlehner, R.A. Hansen, L.C. Morgan, K. Thaler, L. Lux, M. van Noord, U. Mager, P. Thieda, B.N. Gaynes, T. Wilkins, M. Strobelberger, S. Lloyd, U. Reichenpfader, and K.N. Lohr Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis Ann. Intern. Med. 155 2011 772 785
48. ∗D teach us? Results from a large-scale, practical, clinical trial for patients with depression Psychiatr. Serv. 60 2009 1439 1445
49. J.R. Geddes, S.M. Carney, C. Davies, T.A. Furukawa, D.J. Kupfer, E. Frank, and G.M. Goodwin Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review Lancet 361 2003 653 661
50. A.J. Gelenberg A review of the current guidelines for depression treatment J. Clin. Psychiatry 71 2010 e15
51. S. Ghaemi Toward a Hippocratic psychopharmacology Can. J. Psychiatry 53 2008 189
52. S.N. Ghaemi, P.A. Vohringer, and E.A. Whitham Antidepressants from a public health perspective: re-examining effectiveness, suicide, and carcinogenicity Acta Psychiatr. Scand. 127 2013 89 93
53. P. Gilbert The relationship of shame, social anxiety and depression: the role of the evaluation of social rank Clin. Psychol. Psychother. 7 2000 174 189
54. P. Gilbert Evolution and depression: issues and implications Psychol. Med. 36 2006 287 297
55. P. Gluckman, A. Beedle, and M. Hanson Principles of Evolutionary Medicine 2009 Oxford University Press Oxford, UK
56. E. Gortner, J. Gollan, K. Dobson, and N. Jacobson Cognitive-behavioral treatment for depression: relapse prevention J. Consult. Clin. Psychol. 66 1998 377 384
57. M. Grosse Holtforth, A.M. Hayes, M. Sutter, K. Wilm, E. Schmied, J.-P. Laurenceau, and F. Caspar Fostering cognitive-emotional processing in the treatment of depression: a preliminary investigation in exposure-based cognitive therapy Psychother. Psychosom. 81 2012 259 260
58. P. Haddad Antidepressant discontinuation syndromes: clinical relevance, prevention and management Drug Saf. 24 2001 183 197
59. E. Hagen Depression as bargaining: the case postpartum Evol. Hum. Behav. 23 2002 323 336
60. E.H. Hagen The functions of postpartum depression Evol. Hum. Behav. 20 1999 325 359
61. E.H. Hagen Evolutionary theories of depression: a critical review Can. J. Psychiatry 56 2011 716 726
62. B. Harald, and P. Gordon Meta-review of depressive subtyping models J. Affect. Disord. 139 2012 126 140
63. B.L. Hart Biological basis of the behavior of sick animals Neurosci.Biobehav. Rev. 12 1988 123 137
64. A.M. Hayes, C.G. Beevers, G.C. Feldman, J.-P. Laurenceau, and C. Perlman Avoidance and processing as predictors of symptom change and positive growth in an integrative therapy for depression Int. J. Behav. Med. 12 2005 111 122
65. A.M. Hayes, J.P. Laurenceau, G. Feldman, J.L. Strauss, and L. Cardaciotto Change is not always linear: the study of nonlinear and discontinuous patterns of change in psychotherapy Clin. Psychol. Rev. 27 2007 715 723
66. S.D. Hollon, M.E. Thase, and J.C. Markowitz Treatment and prevention of depression Psychol. Sci. Public Interest 3 2002 39 77
67. K. Honkalampi, J. Hintikka, E. Laukkanen, and J.L.H. Viinamäki Alexithymia and depression: a prospective study of patients with major depressive disorder Psychosomatics 42 2001 229 234
68. A.V. Horwitz, and J.C. Wakefield The Loss of Sadness: How Psychiatry Transformed Normal Sorrow into Depressive Disorder 2007 Oxford University Press Oxford
69. I. Ionita-Laza, B. Xu, V. Makarov, J.D. Buxbaum, J.L. Roos, J.A. Gogos, and M. Karayiorgou Scan statistic-based analysis of exome sequencing data identifies FAN1 at 15q13.3 as a susceptibility gene for schizophrenia and autism Proc. Natl. Acad. Sci. USA 111 2014 343 348
70. G. Isacsson, C.L. Rich, J. Jureidini, and M. Raven The increased use of antidepressants has contributed to the worldwide reduction in suicide rates Br. J. Psychiatry 196 2010 429 433
71. N. Jacobson, K. Dobson, P. Traux, M. Addis, K. Koerner, J. Gollan, E. Gortner, and S. Prince A component analysis of cognitive-behavioral treatment for depression J. Consult. Clin. Psychol. 64 1996 295 304
72. M.C. Keller, and G. Miller Resolving the paradox of common, harmful, heritable mental disorders: which evolutionary genetic models work best? Behav. Brain Sci. 29 2006 385 404 (discussion 405-52)
73. M.C. Keller, M.C. Neale, and K.S. Kendler Association of different adverse life events with distinct patterns of depressive symptoms Am. J. Psychiatry 164 2007 1521 1529
74. M.C. Keller, and R.M. Nesse Is low mood an adaptation? Evidence for subtypes with symptoms that match precipitants J. Affect. Disord. 86 2005 27 35
75. M.C. Keller, and R.M. Nesse The evolutionary significance of depressive symptoms: different adverse situations lead to different depressive symptom patterns J. Pers. Soc. Psychol. 91 2006 316 330
76. R.C. Kessler, P. Berglund, O. Demler, R. Jin, D. Koretz, K.R. Merikangas, A.J. Rush, E.E. Walters, and P.S. Wang The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) JAMA 289 2003 3095 3105
77. R.C. Kessler, S. Zhao, D.G. Blazer, and M. Swartz Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey J. Affect. Disord. 45 1997 19 30
78. A. Khan, S. Khan, R. Leventhal, and W. Brown Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration Database Int. J. Neuropsychopharmacol. 4 2001 113 118
79. A. Khan, R.M. Leventhal, S.R. Khan, and W.A. Brown Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database J. Clin. Psychopharmacol. 22 2002 40 45
80. A. Khan, H. Warner, and W. Brown Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database Arch. Gen. Psychiatry 57 2000 311 317
81. I. Kirsch, B.J. Deacon, T.B. Huedo-Medina, A. Scoboria, T.J. Moore, and B.T. Johnson Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration PLoS Med. 5 2008 e45
82. I. Kirsch, T.J. Moore, A. Scoboria, and S.S. Nicholls The emperor's new drugs: an analysis of antidepressant medication data submitted to the U.S. Food and Drug Administration Prev. Treat. 5 2002 1 11
83. I. Kirsch, and G. Sapirstein Listening to Prozac but hearing placebo: a meta-analysis of antidepressant medication Prev. Treat. 1 1998 1 16
84. E. Klinger Consequences of commitment to and disengagement from incentives Psychol. Rev. 82 1975 1 25
85. A. Kong, M.L. Frigge, G. Masson, S. Besenbacher, P. Sulem, G. Magnusson, S.A. Gudjonsson, A. Sigurdsson, A. Jonasdottir, A. Jonasdottir, W.S.W. Wong, G. Sigurdsson, G.B. Walters, S. Steinberg, H. Helgason, G. Thorleifsson, D.F. Gudbjartsson, A. Helgason, O.T. Magnusson, U. Thorsteinsdottir, and K. Stefansson Rate of de novo mutations and the importance of father's age to disease risk Nature 488 2012 471 475
86. V. Krishnan, and E.J. Nestler The molecular neurobiology of depression Nature 455 2008 894 902
87. V. Krishnan, and E.J. Nestler Linking molecules to mood: new insight into the biology of depression Am. J. Psychiatry 167 2010 1305 1320
88. K.M. Krpan, E. Kross, M.G. Berman, P.J. Deldin, M.K. Askren, and J. Jonides An everyday activity as a treatment for depression: the benefits of expressive writing for people diagnosed with major depressive disorder J. Affect. Disord. 150 2013 1148 1151
89. M.E. Kruijshaar, J. Barendregt, T. Vos, R. de Graaf, J. Spijker, and G. Andrews Lifetime prevalence estimates of major depression: an indirect estimation method and a quantification of recall bias Eur. J. Epidemiol. 20 2005 103 111
90. M. Lader Pharmacotherapy of mood disorders and treatment discontinuation Drugs 67 2007 1657 1663
91. T. Laursen, T. Munk-Olsen, M. Nordentoft, and P. Bo Mortensen A comparison of selected risk factors for unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia from a danish population J. Clin. Psychiatry 68 2007 1673 1681
92. A.C. Leon, D.A. Solomon, C. Li, J.G. Fiedorowicz, W.H. Coryell, J. Endicott, and M.B. Keller Antidepressants and risks of suicide and suicide attempts: a 27-year observational study J. Clin. Psychiatry 72 2011 580 586
93. R.W. Levenson The intrapersonal functions of emotion Cogn. Emot. 13 1999 481 504
94. A.J. Lewis Melancholia: a clinical survey of depressive states Br. J. Psychiatry 80 1934 277 378
95. R.L. Lochmiller, and C. Deerenberg Trade-offs in evolutionary immunology: just what is the cost of immunity? Oikos 88 2000 87 98
96. C. Marchesi, E. Brusamonti, and C. Maggini Are alexithymia, depression, and anxiety distinct constructs in affective disorders? J. Psychosom. Res. 49 2000 43 49
97. S.C. Marcus, and M. Olfson National trends in the treatment for depression from 1998 to 2007 Arch. Gen. Psychiatry 67 2010 1265 1273
98. C. Mathers, T. Boerma, and D.M. Fat The Global Burden of Disease: 2004 Update 2008 World Health Organization Geneva, Switzerland
99. J. McClellan, E. Susser, and M. King Maternal famine, de novo mutations, and schizophrenia JAMA 296 2006 582 584
100. M.T. McGuire, I. Marks, R.M. Nesse, and A Troisi Evolutionary biology: a basic science for psychiatry? Acta Psychiatr. Scand. 86 1992 89 96
101. C. McKercher, G.C. Patton, M.D. Schmidt, A.J. Venn, T. Dwyer, and K. Sanderson Physical activity and depression symptom profiles in young men and women with major depression Psychosom. Med. 75 2013 366 374
102. W.R. Miller, and M.E. Seligman Depression and learned helplessness in man J. Abnorm. Psychol. 84 1975 228 238
103. P.B. Mitchell, G.B. Parker, G.L. Gladstone, K. Wilhelm, and M.P. Austin Severity of stressful life events in first and subsequent episodes of depression: the relevance of depressive subtype J. Affect. Disord. 73 2003 245 252
104. T.E. Moffitt, A. Caspi, A. Taylor, J. Kokaua, B.J. Milne, G. Polanczyk, and R. Poulton How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment Psychol. Med. 40 2010 899 909
105. M.A. Nauck, G. Kemmeries, J.J. Holst, and J.J. Meier Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans Diabetes 60 2011 1561 1565
106. R.M. Nesse Evolutionary explanations of emotions Hum. Nat. 1 1990 261 289
107. R.M. Nesse Is depression an adaptation? Arch. Gen. Psychiatry 57 2000 14 20
108. R.M. Nesse, and P.C. Ellsworth Evolution, emotions, and emotional disorders Am. Psychol. 64 2009 129 139
109. R.M. Nesse, and D.J. Stein Towards a genuinely medical model for psychiatric nosology BMC Med. 10 2012 5
110. R.M. Nesse, and G.C. Williams Why we Get Sick: The New Science of Darwinian Medicine 1996 Vintage New York
111. D. Nettle Evolutionary origins of depression: a review and reformulation J. Affect. Disord. 81 2004 91 102
112. D. Nettle An evolutionary model of low mood states J. Theor. Biol. 257 2009 100 103
113. D. Nettle, and M. Bateson The evolutionary origins of mood and its disorders Curr. Biol. 22 2012 R712 R721
114. B.J. O'Roak, L. Vives, S. Girirajan, E. Karakoc, N. Krumm, B.P. Coe, R. Levy, A. Ko, C. Lee, J.D. Smith, E.H. Turner, I.B. Stanaway, B. Vernot, M. Malig, C. Baker, B. Reilly, J.M. Akey, E. Borenstein, M.J. Rieder, D.A. Nickerson, R. Bernier, J. Shendure, and E.E. Eichler Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations Nature 485 2012 246 250
115. S.D. Ostergaard, S.O.W. Jensen, and P. Bech The heterogeneity of the depressive syndrome: when numbers get serious Acta Psychiatr. Scand. 124 2011 495 496
116. E. Palazidou The neurobiology of depression Br. Med. Bull. 101 2012 127 145
117. S.B. Patten Accumulation of major depressive episodes over time in a prospective study indicates that retrospectively assessed lifetime prevalence estimates are too low BMC Psychiatry 9 2009 19
118. E. Penn, and D.K. Tracy The drugs don't work? antidepressants and the current and future pharmacological management of depression Ther. Adv. Psychopharmacol. 2 2012 179 188
119. J. Pennebaker Writing about emotional experiences as a therapeutic process Psychol. Sci. 8 1997 162 166
120. R.A. Power, S. Kyaga, R. Uher, J.H. MacCabe, N. Långström, M. Landen, P. McGuffin, C.M. Lewis, P. Lichtenstein, and A.C. Svensson Fecundity of patients with schizophrenia, autism, bipolar disorder, depression, anorexia nervosa, or substance abuse vs their unaffected siblings JAMA Psychiatry 70 2013 22 30
121. Pratt, L.A., Brody, D.J., Gu, Q., 2011. Antidepressant use in persons aged 12 and over: United States, 2005-2008. NCHS Data Brief 76.
122. J. Price, L. Sloman, R. Gardner, P. Gilbert, and P. Rohde The social competition hypothesis of depression Br. J. Psychiatry 164 1994 309 315
123. J.S. Price, R. Gardner, and M. Erickson Can depression, anxiety and somatization be understood as appeasement displays? J. Affect. Disord. 79 2004 1 11
124. J. Read, C. Cartwright, and K. Gibson Adverse emotional and interpersonal effects reported by 1829 New Zealanders while taking antidepressants Psychiatry Res. 216 2014 67 73
125. E. Rees, G. Kirov, M.C. O'Donovan, and M.J. Owen De novo mutation in schizophrenia Schizophr. Bull. 38 2012 377 381
126. A. Reichenberg, R. Gross, M. Weiser, M. Bresnahan, J. Silverman, S. Harlap, J. Rabinowitz, C. Shulman, D. Malaspina, G. Lubin, H.Y. Knobler, M. Davidson, and E. Susser Advancing paternal age and autism Arch. Gen. Psychiatry 63 2006 1026 1032
127. A.J. Remillard, S.L. Blackshaw, and A. Dangor Differential responses to a single antidepressant in recurrent episodes of major depression Hosp. Community Psychiatry 45 1994 359 361
128. P.A. Resick, P. Nishith, T.L. Weaver, M.C. Astin, and C.A. Feuer A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims J. Consult. Clin. Psychol. 70 2002 867 879
129. S.P. Roose, F. Laghrissi-Thode, J.S. Kennedy, J.C. Nelson, J.T. Bigger, B.G. Pollock, A. Gaffney, M. Narayan, M.S. Finkel, J. McCafferty, and I. Gergel Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease JAMA 279 1998 287 291
130. ∗D: what have we learned? Am. J. Psychiatry 164 2007 201 204
131. ∗D report Am. J. Psychiatry 163 2006 1905 1917
132. A.N. Samaha, P. Seeman, J. Stewart, H. Rajabi, and S. Kapur "Breakthrough" dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time J. Neurosci. 27 2007 2979 2986
133. M.E. Seligman Helplessness: On Depression, Development, and Death 1975 W.H. Freeman, New York
134. M.E.P. Seligman Learned helplessness Annu. Rev. Med. 23 1972 407 412
135. R. Shafran, D.M. Clark, C.G. Fairburn, A. Arntz, D.H. Barlow, A. Ehlers, M. Freeston, P.A. Garety, S.D. Hollon, L.G. Ost, P.M. Salkovskis, J.M. Williams, and G.T. Wilson Mind the gap: improving the dissemination of CBT Behav. Res. Ther. 47 2009 902 909
136. C.F. Sharpley, and V. Bitsika Differences in neurobiological pathways of four "clinical content" subtypes of depression Behav. Brain Res. 256 2013 368 376
137. G.E. Simon, and R.H. Perlis Personalized medicine for depression: can we match patients with treatments? Am. J. Psychiatry 167 2010 1445 1455
138. G.E. Simon, M. Von Korff, C.M. Rutter, and D.A. Peterson Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians Arch. Gen. Psychiatry 58 2001 395 401
139. A. Sipos, F. Rasmussen, G. Harrison, P. Tynelius, G. Lewis, D. a Leon, and D. Gunnell Paternal age and schizophrenia: a population based cohort study BMJ 329 2004 1070
140. L. Sloman, P. Gilbert, and G. Hasey Evolved mechanisms in depression: the role and interaction of attachment and social rank in depression J. Affect. Disord. 74 2003 107 121
141. L. Sloman, and J.S. Price Losing behavior (yielding subroutine) and human depression: proximate and selective mechanisms Ethol. Sociobiol. 8 1987 99 109
142. R.L. Spitzer, and J.C. Wakefield DSM-IV diagnostic criterion for clinical significance: does it help solve the false positives problem? Am. J. Psychiatry 156 1999 1856 1864
143. P.F. Sullivan, M.C. Neale, and K.S. Kendler Genetic epidemiology of major depression: review and meta-analysis Am. J. Psychiatry 157 2000 1552 1562
144. S. Targum Identification and treatment of antidepressant tachyphylaxis Innov. Clin. Neurosci. 11 2014 24 28
145. M.A. Taylor, and M. Fink Restoring melancholia in the classification of mood disorders J. Affect. Disord. 105 2008 1 14
146. B. Thierry, L. Steru, R. Chermat, and P. Simon Searching-waiting strategy: a candidate for an evolutionary model of depression? Behav. Neural Biol. 41 1984 180 189
147. J. Tooby, and L. Cosmides The past explains the present Ethol. Sociobiol. 11 1990 375 424
148. R. Uher The role of genetic variation in the causation of mental illness: an evolution-informed framework Mol. Psychiatry 14 2009 1072 1082
149. M. Valenstein, H.M. Kim, D. Ganoczy, J.F. McCarthy, K. Zivin, K.L. Austin, K. Hoggatt, D. Eisenberg, J.D. Piette, F.C. Blow, and M. Olfson Higher-risk periods for suicide among VA patients receiving depression treatment: prioritizing suicide prevention efforts J. Affect. Disord. 112 2009 50 58
150. B.M. Verdel, P.C. Souverein, T.C.G. Egberts, T.P. van Staa, H.G.M. Leufkens, and F. de Vries Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures Bone 47 2010 604 609
151. L.E.L.M. Vissers, J. de Ligt, C. Gilissen, I. Janssen, M. Steehouwer, P. de Vries, B. van Lier, P. Arts, N. Wieskamp, M. del Rosario, B.W.M. van Bon, A. Hoischen, B.B.A. de Vries, H.G. Brunner, and J.A. Veltman A de novo paradigm for mental retardation Nat. Genet. 42 2010 1109 1112
152. P.A. Vöhringer, and S.N. Ghaemi Solving the antidepressant efficacy question: effect sizes in major depressive disorder Clin. Ther. 33 2011 B49 B61
153. J.C. Wakefield The DSM-5 debate over the bereavement exclusion: psychiatric diagnosis and the future of empirically supported treatment Clin. Psychol. Rev. 33 2013 825 845
154. ∗D project results: a comprehensive review of findings Curr. Psychiatry Rep. 9 2007 449 459
155. ∗D report Am. J. Psychiatry 164 2007 1189 1197
156. P.J. Watson, and P.W. Andrews Toward a revised evolutionary adaptationist analysis of depression: the social navigation hypothesis J. Affect. Disord. 72 2002 1 14
157. C. Wrosch, M. Scheier, C. Carver, and R. Schulz The importance of goal disengagement in adaptive self-regulation: when giving up is beneficial Self Identity 2 2003 1 20
158. B. Xu, J.L. Roos, S. Levy, E.J. van Rensburg, J.A. Gogos, and M. Karayiorgou Strong association of de novo copy number mutations with sporadic schizophrenia Nat. Genet. 40 2008 880 885